Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin

INTRODUCTION: The Alzheimer's disease (AD) process is likely initiated many years before clinical onset. Biomarkers of preclinical disease are critical for the development of disease-modifying or even preventative therapies. Current biomarkers for early disease, including cerebrospinal fluid ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Carro, Eva, Bartolomé, Fernando, Bermejo-Pareja, Félix, Villarejo-Galende, Alberto, Molina, José Antonio, Ortiz, Pablo, Calero, Miguel, Rabano, Alberto, Cantero, José Luis, Orive, Gorka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Diagnostic Assessment & Prognosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470603/
https://www.ncbi.nlm.nih.gov/pubmed/28649597
http://dx.doi.org/10.1016/j.dadm.2017.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470603/
https://www.ncbi.nlm.nih.gov/pubmed/28649597
http://dx.doi.org/10.1016/j.dadm.2017.04.002

Ejemplares similares